These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 636560)

  • 1. [Results of clinical studies on the effect of aggregation inhibitors in arterial diseases].
    Loew D
    Med Welt; 1979 Feb; 30(5):166-9. PubMed ID: 759804
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aggregation inhibitors or anticoagulants in the prevention of peripheral arterial occlusive diseases].
    Loew D; Hess H
    Med Welt; 1982 Oct; 33(43):1511-5. PubMed ID: 6759847
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of platelet aggregation inhibitors on the rate of thrombectomy following arterial reconstructions with Gore-Tex prostheses: a retrospective study.
    Broomé A; Davidsson T; Eklöf B; Hansson L
    Vasa; 1982; 11(3):210-2. PubMed ID: 7136240
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers.
    Caplain H
    Cerebrovasc Dis; 2005; 19(4):214-9. PubMed ID: 15703464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
    Poliwoda H; Avenarius HJ
    Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombocyte-aggregation inhibitors following open or semi-open endarterectomy-preliminary results of a prospective study].
    Vasa; 1978; 7(1):82-5. PubMed ID: 636560
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of acetylsalicylic acid in the secondary prevention of peripheral arterial occlusive diseases].
    Eckstein HH; Müller-Bühl U; Zimmermann R; Diehm C
    Dtsch Med Wochenschr; 1988 May; 113(20):822-7. PubMed ID: 2967171
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preventive treatment of cerebrovascular accidents of arterial origin].
    Castillo V; Bogousslavsky J; Vuadens P
    Praxis (Bern 1994); 1996 Feb; 85(6):159-63. PubMed ID: 8701178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Platelet antiaggregants and arteriopathies].
    Cristol R
    J Mal Vasc; 1981; 6(3):237-41. PubMed ID: 7026714
    [No Abstract]   [Full Text] [Related]  

  • 10. [Specific measures in drug therapy in stroke. Anticoagulants, inhibitors of thrombocyte aggregation, initial barbiturate therapy].
    Soyka D
    Nervenarzt; 1980 Aug; 51(8):443-8. PubMed ID: 7003417
    [No Abstract]   [Full Text] [Related]  

  • 11. [Technological and biopharmaceutical aspects. Antiplatelet agents for oral administration].
    Breitkreutz J
    Pharm Unserer Zeit; 2009; 38(4):330-7. PubMed ID: 19572353
    [No Abstract]   [Full Text] [Related]  

  • 12. Semi-closed femoropopliteal thromboendarterectomy: a prospective study.
    Heider P; Hofmann M; Maurer PC; von Sommoggy S
    Eur J Vasc Endovasc Surg; 1999 Jul; 18(1):43-7. PubMed ID: 10388638
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.